ClinicalTrials.Veeva

Menu

ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in Children (ENIGMA)

Sanofi logo

Sanofi

Status and phase

Completed
Phase 3

Conditions

Gastroenteritis

Treatments

Other: Oral rehydration therapy
Drug: Bacillus Clausii

Study type

Interventional

Funder types

Industry

Identifiers

NCT00457353
ENTER_L_01486

Details and patient eligibility

About

Primary:

  • To demonstrate the efficacy of Enterogermina® in reducing the duration of acute diarrhea in children

Secondary:

  • To evaluate the safety of Enterogermina® in acute diarrhea in Indian children

Enrollment

264 patients

Sex

All

Ages

6 months to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Non hospitalised infants and children attending clinic/outpatients with acute diarrhea (>3 liquid or watery stools occurring in a 24-hour period) of less than 48 hours duration

Exclusion criteria

  • History of presence of blood, pus, or mucus in stools
  • Severe dehydration (World Health Organization criteria)
  • Severely malnourished patients
  • Treatment with antibiotics, probiotics, or prebiotics within a period of 2 weeks before enrolment
  • History of conditions known to producing immunodeficiency (Acquired Immune Deficiency Syndrome, other congenital immunodeficiency syndrome, drug therapy with steroids, anticancer drugs etc)
  • Known hypersensitivity to Bacillus clausii or other probiotics.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

264 participants in 2 patient groups, including a placebo group

1
Active Comparator group
Description:
Administration of oral rehydration therapy with Bacillus clausii probiotic strain (1 vial twice daily, each vial containing 2 billion spores of Bacillus clausii)
Treatment:
Drug: Bacillus Clausii
2
Placebo Comparator group
Description:
Administration of Oral rehydration therapy
Treatment:
Other: Oral rehydration therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems